Literature DB >> 12651876

How to identify the genetic basis of gastrointestinal and liver diseases?

P Ferenci1.   

Abstract

New insights into the genetic basis of disease are being generated at an ever increasing rate. This explosion of information was ignited by technological advances, such as the polymerase chain reaction and automated DNA sequencing. Although its promise is great, the integration of genetics into the everyday practice of medicine remains challenging. This review discusses the application of molecular genetics in general with a specific focus on hereditary diseases of the digestive organs. The application of molecular genetics in everyday clinical routine is hampered by the difficult interpretation of test results. These difficulties include the prediction of disease penetrance, the presence of multiple mutations of a particular gene with varying functional consequences, and the importance of exogenous factors modulating disease expression. To date, the most significant impact of genetics has been to increase our understanding of disease aetiology and pathogenesis and to reliably identify siblings of affected patients with the risk to develop symptomatic disease.

Entities:  

Mesh:

Year:  2003        PMID: 12651876      PMCID: PMC1867749          DOI: 10.1136/gut.52.suppl_2.ii6

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  30 in total

1.  Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. American College of Gastroenterology.

Authors:  D K Rex; D A Johnson; D A Lieberman; R W Burt; A Sonnenberg
Journal:  Am J Gastroenterol       Date:  2000-04       Impact factor: 10.864

Review 2.  Alpha1-antitrypsin deficiency--a model for conformational diseases.

Authors:  Robin W Carrell; David A Lomas
Journal:  N Engl J Med       Date:  2002-01-03       Impact factor: 91.245

3.  Clinical practice. Screening for colorectal cancer.

Authors:  David F Ransohoff; Robert S Sandler
Journal:  N Engl J Med       Date:  2002-01-03       Impact factor: 91.245

4.  Detection of APC mutations in fecal DNA from patients with colorectal tumors.

Authors:  Giovanni Traverso; Anthony Shuber; Bernard Levin; Constance Johnson; Louise Olsson; David J Schoetz; Stanley R Hamilton; Kevin Boynton; Kenneth W Kinzler; Bert Vogelstein
Journal:  N Engl J Med       Date:  2002-01-31       Impact factor: 91.245

Review 5.  Hemochromatosis.

Authors:  L W Powell; T R Yapp
Journal:  Clin Liver Dis       Date:  2000-02       Impact factor: 6.126

Review 6.  The ABC of APC.

Authors:  N S Fearnhead; M P Britton; W F Bodmer
Journal:  Hum Mol Genet       Date:  2001-04       Impact factor: 6.150

7.  Automated measurement of unsaturated iron binding capacity is an effective screening strategy for C282Y homozygous haemochromatosis.

Authors:  P E Hickman; L F Hourigan; L W Powell; F Cordingley; G Dimeski; B Ormiston; J Shaw; W Ferguson; M Johnson; J Ascough; K McDonell; A Pink; D H Crawford
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

Review 8.  Chronic pancreatitis: diagnosis, classification, and new genetic developments.

Authors:  B Etemad; D C Whitcomb
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

9.  Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations.

Authors:  J Hampe; A Cuthbert; P J Croucher; M M Mirza; S Mascheretti; S Fisher; H Frenzel; K King; A Hasselmeyer; A J MacPherson; S Bridger; S van Deventer; A Forbes; S Nikolaus; J E Lennard-Jones; U R Foelsch; M Krawczak; C Lewis; S Schreiber; C G Mathew
Journal:  Lancet       Date:  2001-06-16       Impact factor: 79.321

Review 10.  'CFTR-opathies': disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations.

Authors:  P G Noone; M R Knowles
Journal:  Respir Res       Date:  2001-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.